Viewing Study NCT02641002


Ignite Creation Date: 2025-12-25 @ 3:52 AM
Ignite Modification Date: 2026-03-03 @ 3:03 PM
Study NCT ID: NCT02641002
Status: TERMINATED
Last Update Posted: 2018-10-18
First Post: 2015-11-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS)
Sponsor: Celgene
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-03-01
Start Date Type: ACTUAL
Primary Completion Date: 2018-07-18
Primary Completion Date Type: ACTUAL
Completion Date: 2018-07-18
Completion Date Type: ACTUAL
First Submit Date: 2015-11-12
First Submit QC Date: None
Study First Post Date: 2015-12-29
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-10-17
Last Update Post Date: 2018-10-18
Last Update Post Date Type: ACTUAL